NCT07341516
Worldwide Assessment of Deceased Donor Kidney Utilization
Enrolling by Invitation
Not specifiedAll AgesObservationalParis Translational Research Center for Organ TransplantationInvestigator-initiated
~300,000 participants
Updated 2026-01-14 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Kidney allograft discard
Measured over Day 0
Conditions
Where it's being run
2 sites across 2 statesTennessee1
France1
Study leadership
- Alexandre Loupy, MD, PhD · PRINCIPAL_INVESTIGATOR · Paris Institute for Transplantation and Organ Regeneration, INSERM, UMR-S970, Paris, France
- Peter P Reese, MD, PhD · PRINCIPAL_INVESTIGATOR · Vanderbilt Center for Transplant Science, Vanderbilt University Medical Center, Nashville, TN, USA
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
All consecutive kidneys recovered for the purpose of transplantation from donors deceased from brain death or circulatory death between January 1, 2010 and December 31, 2025
Exclusion
Kidneys offered to transplant centers but never recovered
Living renal transplants
Multiorgan transplant recipients
What this trial measures
- Kidney allograft discardDay 0
defined as kidneys recovered for transplantation but not transplanted.